Lv1
69 积分 2023-11-11 加入
Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T‐cells
2小时前
已关闭
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma
1个月前
已完结
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma
1个月前
已关闭
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma
1个月前
已关闭
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
2个月前
已完结
Clinical Mass Spectrometry Approaches to Myeloma and Amyloidosis
2个月前
已完结
Monoclonal Gammopathy of Renal Significance
2个月前
已完结
Mass Spectrometry-Based Assessment of M-protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma
3个月前
已完结
Mass Spectrometry Imaging in Alzheimer's Disease
4个月前
已完结
Comparison of the Analytical Performance of EXENT®, a Mass Spectrometry-Based Assessment of M-Protein, to SPEP and NGS-Based MRD in Multiple Myeloma Patient Samples
5个月前
已完结
皖公网安备34019202002308
